NR1H4 and fatty liver disease: In summary, puerarin ameliorates HFD-induced alterations in gut microbiota, particularly in normal mice, while FXR deficiency leads to a distinct microbiota profile, underscoring the relevance of gut microbiota in fatty liver disease development and the potential of puerarin as a therapeutic intervention.